Compounds > cromolyn sodium
Page last updated: 2024-08-23

cromolyn sodium and Angiogenesis, Pathologic

cromolyn sodium has been researched along with Angiogenesis, Pathologic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, R; Ben-Batalla, I; Bokemeyer, C; Cubas Córdova, M; Egberts, J; Hauser, C; Janning, M; Legler, K; Loges, S; Pantel, K; Schulze, C; Udonta, F; Velthaus, J; Wroblewski, M1
Cimpean, AM; Raica, M1
Bartelds, B; Berger, RMF; Boersma, B; Dickinson, MG; Mohaupt, S; Takens, J; van Albada, M; van Loon, RLE; Wijnberg, H1
Biedermann, T; Eichner, M; Haubner, R; Hültner, L; Illges, H; Kneilling, M; Krenn, V; Mailhammer, R; Morawietz, L; Pichler, BJ; Röcken, M; Sabatino, J; Solomon, S; Weber, WA1
Theoharides, TC1
Arnold, F1

Other Studies

6 other study(ies) available for cromolyn sodium and Angiogenesis, Pathologic

ArticleYear
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B.
    Nature communications, 2017, 08-16, Volume: 8, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Anti-Asthmatic Agents; Cell Line, Tumor; Cell Proliferation; Cromolyn Sodium; Endothelial Cells; Extracellular Matrix; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Granulocyte-Macrophage Colony-Stimulating Factor; Granzymes; Human Umbilical Vein Endothelial Cells; Laminin; Mast Cells; Mice; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vitronectin

2017
The Hidden Side of Disodium Cromolyn: from Mast Cell Stabilizer to an Angiogenic Factor and Antitumor Agent.
    Archivum immunologiae et therapiae experimentalis, 2016, Volume: 64, Issue:6

    Topics: Angiogenesis Inducing Agents; Animals; Anti-Asthmatic Agents; Antineoplastic Agents; Becaplermin; Blood Vessels; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Cromolyn Sodium; Female; Humans; Mast Cells; Melanoma; Middle Aged; Necrosis; Neovascularization, Pathologic; Proto-Oncogene Proteins c-sis; Vascular Endothelial Growth Factor A

2016
Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.
    Chest, 2012, Volume: 141, Issue:3

    Topics: Animals; Cell Proliferation; Chymases; Cromolyn Sodium; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Lung; Male; Mast Cells; Monocrotaline; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Rats; Rats, Wistar; Sulfonamides; Thiophenes

2012
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.
    Arthritis and rheumatism, 2007, Volume: 56, Issue:6

    Topics: Albuterol; Animals; Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Cromolyn Sodium; Cyclic AMP; Disease Models, Animal; Female; Glucose-6-Phosphate Isomerase; Integrin alphaVbeta3; Joint Diseases; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Neovascularization, Pathologic

2007
Mast cells and pancreatic cancer.
    The New England journal of medicine, 2008, Apr-24, Volume: 358, Issue:17

    Topics: Animals; Cell Transformation, Neoplastic; Chemokine CCL2; Cromolyn Sodium; Mast Cells; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc

2008
Exploiting angiogenesis.
    Lancet (London, England), 1991, Apr-06, Volume: 337, Issue:8745

    Topics: Cromolyn Sodium; Humans; Neoplasms; Neovascularization, Pathologic; Palliative Care

1991